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Abstract
       Breast cancer is a leading cause of death amongst women, 
several studies have shown significant association between alcohol 
consumption and breast cancer. The aim of this overview is to high-
light some of the mechanisms by which alcohol consumption could 
increase the risk of developing breast cancer. Using online Medline 
search engine, article containing details about mechanisms which 
explain the link between alcohol and breast cancer were examined. 
A number of mechanisms were found by which alcohol could in-
crease the risk of breast cancer, alcohol’s interaction and effect on 
oestrogen secretion; number of oestrogen receptors; the generation 
of acetaldehyde and hydroxyl free radicals; cells migration and me-
tastasis; secretion of IGF1 and interaction with HRT and folate me-
tabolism. In conclusion, it is essential for clinicians to understand 
these mechanisms and inform patients of the link between alcohol 
and breast cancer.
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Introduction
 Breast cancer is now the most common cancer in the 
UK.  In 2005 more than 45,500 women were diagnosed with 
breast cancer, that’s around 125 women a day [1]. Breast 
cancer is also the leading cause of death amongst women at 
a 17.4% of total [2]. Risk factors are associated with almost 
every aspect of women’s lives. Family history, life style, 
diet, smoking and alcohol are all on the list of increasing the 
susceptibility to breast cancer.
  As the concern for breast cancer is increasing, studies 
have been conducted in all the different aspects of women’s 
lives trying to find out what could reduce the risk of breast 
cancer, and what could increase it. One of those important 
aspects is alcohol consumption.
 A significant association between alcohol intake and 
breast cancer has been found, with an increase of risk of 7% 
for each additional 10 grams of alcohol consumed on a daily 
basis [3]. 
  The aim of this overview is to highlight some of the 
mechanisms by which alcohol consumption could increase 
the risk of developing breast cancer.
 
Alcohol metabolism
 Ethanol metabolism is often considered to be the pre-
dominant  factor  in  the  onset  of  tissue  damage,  notably 
through the formation of acetaldehyde. Ethanol metabolism 
occurs predominantly in the liver, although a variety of other 
tissues have a significant capacity for ethanol metabolism. 
Acetaldehyde is the primary product of ethanol oxidation, 
irrespective of whether it is mediated by aldehyde dehydro-
genase (ADH), cytochrome P-450 isoforms, or catalase. 
  Acetaldehyde is itself oxidised predominantly by means 
of a highly efficient aldehyde dehydrogenase (ALDH2), lo-
calised in the mitochondrial matrix. As a result, both cellular 
and  circulating  concentrations  of  acetaldehyde  are  main-
tained in the low micromolar range despite elevated blood 
ethanol concentrations. 
  The rate of both ethanol oxidation and acetaldehyde ox-
idation is determined by the rate of NADH oxidation through 
mitochondrial electron transport. This activity depends on 
the supply of other substrates, the demand for ATP in the 
cell, and the supply of oxygen. 
  An inadequate electron transport activity would result 
not only in an inefficient removal of ethanol and acetalde-
hyde and a highly reduced state of both cytosolic and mi-
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tochondrial nicotinamide adenine dinucleotide (NAD), but 
also promote the overflow of electrons passing through the 
mitochondrial electron transport chain into the formation of 
reactive oxygen species (ROS), notably superoxide [4].
 
Alcohol and women
  Reporting drinking habits can sometimes be difficult, 
and so the patient tends not to mention that they drink alco-
hol regularly or in some cases, the clinician doesn’t even ask.
  It is widely reported that women often drink less and 
have a lower prevalence of drinking problems than men, but 
this is starting to change. As drinking levels in women be-
gin to approach those in men, rates of drinking problems in 
women are likely to overtake those of men, as women have 
greater physiological sensitivity to the effects of alcohol [5].
   This physiological sensitivity is probably due to wom-
en’s lower total body water, gender differences in alcohol 
metabolism, and effects of alcohol on postmenopausal oes-
trogen levels. Mortality and breast cancer are increased in 
women who report drinking more than two drinks daily [6]. 
 Many women have read studies linking hormone re-
placement therapy (HRT) use with increased breast cancer 
incidence. It’s due to this that they may avoid HRT. The link 
between alcohol use and breast cancer risk, in contrast, is 
at least as strong as that of (HRT), yet little publicity has 
reached practising physicians or patients [7]. Much of the 
concentration has been made of smoking, HRT and diet, with 
alcohol left out.
Some  evidences  for  alcohol  increasing  the 
risk of breast cancer
  
 Two types of research link alcohol and cancer. Epide-
miological research has shown a dose-dependent association 
between alcohol consumption and breast cancer; as alcohol 
consumption increases, so does risk of developing certain 
cancers. More tenuous results have come from research into 
the mechanism by which alcohol could contribute to cancer 
development. Smith et al [8] found that alcohol intake of at 
least 30g daily over a period of years increased the risk of 
breast cancer by 30 to 40% compared with non-drinkers.
 Moderate consumption of alcohol (0.07 g/kg) by women 
who use hormone replacement therapy, was found to elevate 
oestradiol (high levels are risk factors for breast cancer) level 
beyond exceeding the ovulatory range for four hours [9].
   For postmenopausal women even less than one drink a 
day was associated with up to a 30% increase in breast can-
cer mortality compared to non-drinkers [10].
   In 2004 and their review G. Poschl and H. K. Seitz [11] 
found that 84% of the 69 case–control and 76% of the 21 
cohort studies published so far showed a positive association 
between ethanol intake and breast cancer.
   Analyses included 58 515 women with invasive breast 
cancer and 95 067 controls from 53 studies. The average 
consumption of alcohol reported by controls from developed 
countries was 6.0 g per day, i.e. about half a unit/drink of 
alcohol per day, and was greater in ever-smokers than nev-
er-smokers, (8.4 g per day and 5.0 g per day, respectively). 
Compared with women who reported drinking no alcohol, 
the relative risk of breast cancer was 1.32 (1.19 – 1.45, P < 
0.00001) for an intake of 35 – 44 g per day alcohol, and 1.46 
(1.33 – 1.61, P < 0.00001) for ≥ 45 g per day alcohol. 
 It is interesting to note that the relationship between 
smoking  and  breast  cancer  was  substantially  confounded 
by the effect of alcohol. When analyses were restricted to 
22 255 women with breast cancer and 40 832 controls who 
reported drinking no alcohol, smoking was not associated 
with breast cancer (compared to never-smokers, relative risk 
for ever-smokers = 1.03, 95% CI 0.98 – 1.07, and for cur-
rent smokers = 0.99, 0.92–1.05). If the observed relationship 
for alcohol is causal, these results suggest that about 4% of 
the breast cancers in developed countries are attributable to 
alcohol [3].
Proposed mechanisms for alcohol effect
Alcohol and oestrogen
      Oestrogen is a hormone largely produced (in women) 
by ovaries. When ovarian production of oestrogen ends, adi-
pose cells are important sites for the conversion of androgen-
ic precursors from the adrenal gland to oestrogen. Moderate 
alcohol consumption was found to be associated with elevat-
ing oestrogen levels in the blood [9].
        Oestrogen has many biological effects; amongst them 
is a proliferative action. Many lines of breast cancer cells 
depend on oestrogen and progesterone in growth.
That means that the breast cells would be exposed to higher 
levels of oestrogen if women consumed alcohol. This may in 
turn trigger the cells, which are oestrogen sensitive in these 
women, to become cancerous.
Alcohol  consumption-related  increases  in  oestrogen 
levels may in turn be partially responsible for the associated 
decreased risk for coronary artery disease and osteoporosis, 
as well as for increased risk for breast cancer [12].
         Alcohol could increase plasma oestrogen levels either 
by promoting the induction of aromatases, which can con-
vert androgens to estrogens, or by impairing the metabolism 
of oestrogen in liver, resulting in oestrogen accumulation in 
the circulation [13].
      This association between alcohol and high oestrogen 
levels was supported by findings in premenopausal women, 
as well as postmenopausal [14]. 
Chronic alcohol intake is associated with ovarian fail-
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ure, infertility and early menopause, i.e. alcohol has a dam-
aging effect on the female reproductive system. Thus, in pre-
menopausal women, the alcohol effect could be via an effect 
on the pituitary–ovarian axis [15].
Alcohol and oestrogen receptors
Another  suggested  mechanism  is  ethanol  effect  on 
level and activity oestrogen receptors on the human breast 
cancer cells. The oestrogen receptors are members of the 
steroid hormone receptor family, which are nuclear recep-
tors. They are capable of eliciting a variety of cell responses 
and influencing signal transduction pathways both in ligand-
dependent and ligand-independent manners.
Not all cancer cells have oestrogen receptor. An in-
teresting study was carried by Keith et al [16] to determine 
whether exposure to ethanol at physiologically relevant con-
centrations would affect oestrogen receptors of breast cancer 
cells. The alcohol concentrations used were of moderate to 
high alcohol intake; i.e. up to three drinks a day and so hav-
ing blood ethanol level of 5 to 24 mM.
      Positive results for cells with oestrogen receptors in-
cluded: increase in cell proliferation, increased cAMP pro-
duction, enhanced DNA synthesis, and increased number of 
oestrogen receptors.
         The elevated level of cAMP was suggested as a mecha-
nism for the effects of ethanol on cell proliferation, but the 
results did not support this, as cAMP levels were not consis-
tent with cell proliferation. Bearing in mind that the ethanol-
cAMP relationship is tissue specific and so depends on the 
tissue examined. 
      Another proposed mechanism was through affecting 
oestrogen receptors’ numbers. Despite the fact that total cell 
numbers increased at ethanol levels lower than those needed 
to elevate receptors’ numbers, the other component for etha-
nol effect (increasing the receptor activity) is still a possibil-
ity.
          From this study it might appear that ethanol only affects 
human  cancer  cells  with  oestrogen  receptors  and  not  the 
others. But, there is recent evidence that ethanol intake by 
women may increase the risk of developing breast tumours 
with oestrogen or oestrogen and progesterone receptors [17]. 
Alcohol and carcinogenics  
       Another possibility is that alcohol is converted to car-
cinogenic substances inside the human body. Oxidation of 
ethanol to acetaldehyde and the generation of free radicals 
were studied by Castro et al [18]. Acetaldehyde is a transi-
tional compound in the oxidation of ethanol and acetic acid. 
It is carcinogenic compound; it is easily oxidised and po-
tentially generating free hydroxyl radicals (carcinogenics). 
Furthermore, acetaldehyde is also known to be able to in-
hibit O6-methyl guanine demethylase, which is known to be 
critical for the repair of O6-methyl guanine lesions in DNA 
caused by N-nitrosodimethylamine and of other equivalent 
alterations resulting from other alkylating carcinogens [10].  
        The enzymes involved in oxidation of acetaldehyde 
to acetate are xanthine dehydrogenase (XDh) and xanthine 
oxidase (XO). Both XOR and AOX can generate reactive 
oxygen species (ROS), e.g. superoxide anion (O2-), hydroxyl 
radical (·OH), and hydrogen peroxide (H2O2).
           ROS cause numerous modifications to DNA, contribut-
ing to carcinogenesis and breast cancer.
        They need cosubstrates that help them speed the reac-
tion, e.g. NAD+ and caffeine (which is widely available in 
soft drinks). The study [18] found that incubation of the en-
zymes with their cosubstrates has significantly increased the 
generation of acetaldehyde and hydroxyl free radicals.
Alcohol and metastasis
        In addition for being carcinogenic, and helping in pro-
moting tumour growth via oestrogen levels, alcohol is being 
investigated for its role in metastasis. Metastasis is the pro-
cess of tumour cells detaching from primary site and spread-
ing to secondary sites within the human body. It is essential 
for the cells to detach themselves form the original tissue, 
be able to attach to extracellular matrix, degradation of ex-
tracellular structures and then invade the tissue and the sur-
rounding vessels.
          Cells use specific interaction molecules to maintain tis-
sue integrity. Two major groups of these are the E-cadherin 
(transmembrane  glycoprotein)  and  catenins  (cytoplasmic 
proteins, that link E-cadherin to actin filaments) [19]. In a 
study conducted by Meng et al [20], in vitro cells were in-
cubated with biologically significant alcohol concentrations 
(40 - 80 mM). This range of concentrations was calculated 
at the beginning of the experiment, after no cytotoxicity of 
alcohol was observed below 100mM.  As the first step was 
detachment of cells from original tissue, treated and untreat-
ed cancer cells were lysed in a solution with antibodies for 
E-cadherin and catenins.  Using a detection system, it was 
found that exposure to alcohol resulted in dose-dependent 
downregulation of E-cadherin expression. A parallel down 
expression of catenins was recorded.
       For all the other necessary steps for metastasis, it was 
found that alcohol has a promoting effect of cell adhesion to 
basement membrane extract and stimulation of cell invasion 
and migration. 
       Increasing the motility of cells is essential for cell mi-
gration. To examine this, a monolayer of cells was scratched 
with a sterile tip (a minor wound was created). With alcohol 
presence, cell flattening and spreading was significantly en-
hanced along the edges of the wound, compared to untreated 
samples. 
The human breast cancer cells were incubated with 
Matrigel basement membrane extract.  At alcohol concentra-
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tion of 80mM, adhesion of the cancer cells was significantly 
enhanced. 95% of cells were attached compared to only 65% 
in absence of alcohol.
The invasion step is a complex one; it involves se-
creting enzymes to dissolve the tissue material followed by 
increased motility. This was tested on invasion of Matrigel 
basement membrane extract. When 40 and 80 mM of alcohol 
were present, the invasion increased by approximately 23% 
and 52% compared with untreated control, respectively.
Even from a protective prospective, alcohol had a neg-
ative effect. BRCA1 (breast cancer susceptibility gene 1) is 
a human gene that is associated with suppression of breast 
carcinoma [21].  It is only found in low-grade tumours and 
its absence is associated with high grade (invasive) ones. Al-
cohol resulted in down expression of BRCA1 gene in a dose 
dependent manner [20].
Alcohol and HRT
Another set of studies found that women using the 
hormone replacement therapy (HRT) and drinking alcohol 
were at higher risk of developing breast cancer. The extent 
of impact reached a 3-fold increase in circulating oestradiol 
on alcohol ingestion (0.7 g/kg/day), for women using HRT 
[22]. Gapstur [23] has even concluded that the increased risk 
of breast cancer was confined to this group (rather than users 
of HRT only). 
HRT is the administration of the female hormones oes-
trogen and progesterone.  The use of hormone replacement 
therapy is highly effective for improving the quality of life 
of women suffering from acute symptoms of menopause, 
such as hot flashes, night sweats, insomnia, increased fatigue 
and irritability. It is also thought that HRT provides some 
long-term protection against cardiovascular disease and os-
teoporosis.
       The explanation for the study findings is very impor-
tant. When no explanation could be found, it discourages 
from emphasising the link between a factor and the stud-
ied condition.  The same thing happened with alcohol and 
breast cancer, as no biological explanation could be found 
for any association, and thus alcohol was not mentioned in 
some studies that explored HRT and breast cancer. Mills et 
al [24] described the association as a “nuisance factor” and 
was viewed as “unexpected and intriguing. Further study is 
needed....” by Colditz et al [25].
      The findings that brought alcohol as the major factor 
to increase the risk of breast cancer, and not oestrogen sup-
plements (and the fact that there has been no studies that 
disagreed with those findings), led Zumoff [26] to come up 
with a hypothesis that states the following: (1) Oestrogen ad-
ministration to postmenopausal women elevates oestradiol 
levels modestly. It might increase the level near the thresh 
hold for breast cancer, but it does not increase the risk un-
less the patient is genetically susceptible. (2) If alcohol is 
consumed, women receiving oestrogen replacement therapy 
will have increased level of oestradiol above thresh hold of 
breast cancer promoting effects. This is regardless of the ge-
netic background.
Alcohol and insulin like growth factors (IGF)
       From mammography screening, a peak incidence for 
duct carcinoma in situ (DCIS) of the breast is seen at the 
age of 45–50 years followed by a steady decline [27]. It sug-
gests that as the menopause approaches, a high proportion 
of precancerous lesions in the breast undergo spontaneous 
resolution. Two mechanisms for that have been proposed: 
the falling oestrogen level and programmed cell death (apop-
tosis) [28].  
This  observation  may  suggest  that  mechanisms  of 
breast cancer associated with alcohol are likely to be differ-
ent in premenopausal from postmenopausal. In postmeno-
pausal disease, it may involve a promoting role of hyperin-
sulinaemia.
          One of the most known consequences of chronic alco-
hol consumption is liver cirrhosis.  Nearly all patients with 
liver cirrhosis are insulin resistant, β-cells respond to this re-
sistant by increasing insulin levels (hyperinsulinaemia) [29]. 
      In a review by Stoll [30], the elevated levels of the 
growth hormone/insulin-like growth factor 1 (GH/IGF1) that 
accompanied hyperinsulinaemia were studied as proposed 
mechanism for promotion of mammary carcinogenesis. 
           The liver is the major source of circulating IGF1 and at 
least six IGF-binding proteins (IGFBPs).  The bioavailabil-
ity of circulating IGF1 is regulated by the different IGFBPs.   
Whereas IGFBP1 regulates IGF1 availability in response to 
rapid changes in insulin levels, over 90% of circulating IGF1 
is bound to IGFBP3, the latter controls long-term adaptive 
change to long-term hyperinsulinaemia.
        In normal subjects, the effect of insulin is to suppress 
free IGF1 and IGFBP1 concentrations, but IGFBP3 concen-
trations are stimulated.  But in patients with alcoholic cir-
rhosis, hyperinsulinaemia decreases IGFBP3 concentrations, 
resulting  in  increased  IGF1  bioactivity,  which  stimulates 
insulin-like growth factor 1 receptor IGF1R activity in mam-
mary tissue cells.
       IGF1 has been shown to induce proliferative activity 
in cells that have undergone transformation [31]. Although 
these cells could obviously be benign, (IGF1R) is a protein 
that is thought to have a crucial role in mitogenesis (stimulat-
ing mitosis) and transformation to the malignant phenotype.
          All the above is through the effect of IGF1, but insulin 
itself may have a role in mammary carcinoma.  Most breast 
cancer  specimens  show  both  IGF1  and  insulin  receptors.   
Over-expression of insulin receptors (IR) has been noted in 
human breast cancer cells and this may make them more re-
sponsive to insulin stimulation [32]. 
         Another possible route for IGF1 to affect human breast 
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cancer cells is via its interaction with oestrogen.  Both oes-
trogen and IGF1 are potent mitogens for most human breast 
cancer cell lines, interaction between their receptors is like-
ly to be involved in modulating the progress of mammary 
carcinogenesis [26]. In most breast cancer cell lines IGF1 
stimulates ER expression, whilst oestrogen increases the ex-
pression of IGF1R [33]. 
       The above evidences for IGF1 effects on breast cancer 
cells, and the how its levels are indirectly affected by alcohol 
(via hyperinsulinaemia), all that led Stoll [25] to come up 
with the hypothesis that alcohol only affects postmenopausal 
women as a promoter for carcinogenesis, via IGF1.
       Whilst IGF1 might synergies with oestrogen in a mito-
genic effect on mammary epithelium and at the same time 
prevent apoptosis, IGFBP3 might limit the bioavailability of 
IGF1 and at the same time increase apoptosis independently 
of IGF1.
Alcohol and folate
       The important link between alcohol and folate is that 
alcohol is a folate antagonist.
This action of alcohol was investigated by Zhang et al [34] 
in a study to test whether high folate intake (compensating 
for the alcohol effect) would reduce the risk of breast cancer.
The study found that the risk for breast cancer was 
higher in women who consumed at least 15g/day of alcohol 
with low folate intake. High intake of folate had a reducing 
effect on breast cancer; with at least 600 microgram/day of 
folate, the risk of breast cancer was reduced by 0.45%, com-
pared with 150-299 microgram/day.
       The association between alcohol and breast cancer was 
observed again; women (with folate intake >300 microgram/
day) consuming >15 g/day of alcohol had an 5% increased 
risk of breast cancer compared with < 15 g/day.
      It has long been known that folate can help prevent 
certain spinal cord birth defects, which is why it is recom-
mended as a supplement for women of child-bearing age. 
        The protective role of folate from cancer has been stud-
ied by Shrubsole et al [35]. The study tested the hypothesis 
that high intake of folate may reduce the risk of human can-
cers, including breast cancer. 
       Folate is a B vitamin found naturally in many foods, 
including dry beans, peas, and leafy green vegetables, such 
as spinach. It is essential for regenerating methionine, which 
is the methyl donor for DNA methylation and for purines and 
pyramidines required for DNA synthesis. Folate co-factors 
(vitamin B6 and B12) have important roles in folate metabo-
lism. Vitamin B6 is coenzyme in the conversion of folate to 
the form used in DNA synthesis, and vitamin B12 facilitates 
methyl transfer.
       The body is able to absorb folic acid (used in fortifying 
foods and in supplements) about twice as easily as the folate 
found naturally in foods. The recommended daily intake of 
folate for adults is at least 400 micrograms (ug). 
        The study evaluated the association between folate and 
breast cancer in a population who lived in Shanghai, China. 
It was important that the study is not conducted in a western 
country. The reason for this is fortification of food. Since 
1998, folic acid fortification of cereal food has been man-
dated in the USA. Therefore studies in North America might 
lack the appropriate food composition; thus it would not be 
possible to assess the exact folate intake of the population. 
      The Shanghai population included women who have 
diet composed of unfortified and unprocessed food. And they 
rarely take vitamin supplements that might result in miscal-
culations of total folate intake. Also in the population, few 
women drink regularly. This is significant to evaluate the ef-
fect of folate, independently from other factors.
          The study found that high intake of folate was associat-
ed with 0.38 % reduction of breast cancer. Folate co-factors 
intake was assessed as well. It was found that women with 
high levels of folate co-factors intake had a 0.53% reduction 
of breast cancer.
Although the inverse association (between folate in-
take and breast cancer) was more evident in postmenopausal 
women,  similar  pattern  of  association  was  found  in  pre-
menopausal women.
       This led Shrubsole et al [35]  to come up with several 
possible mechanisms to explain why folate deficiency might 
contribute to cancer development: (1) Folate is converted 
to its active form tetrahydrofolic acid (THF). THF acts as 
a carrier compound, carrying methyl group (5-mythyl THF) 
to specific structured that are being synthesised or modified 
[36]. Methylation is important for gene expression. Folate 
deficiency may lead to global hypomethylation, which has 
been linked mutation via genomic instability. (2) Methionine 
is converted into S-adenosylmethionine (SAM), which is the 
major methyl group donor in DNA synthesis. When folate 
level is low, SAM formation may take precedence over thy-
mine synthesis. Low thymine might results in misincorpora-
tion of uracil into DNA and higher levels of chromosomal 
breaks. (3) Although contrary, folate deficiency might result 
in hypermethylation of specific tumour suppresser genes, re-
ducing their expression. 
The alcohol intervention with folate occurs at several 
aspects  of  folate  transport  and  metabolism,  disrupting  its 
supply to tissues. They include: intestinal absorption, trans-
port to tissue, storage and release by liver [35].
         Thus, alcohol could be taken as a factor that reduces fo-
late supply to tissues; this in its turn results in disrupted gene 
expression and DNA breakage, which are major risk factors 
for cancer development.
Conclusions
  Breast cancer is the most common cause of cancer 
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death in women world-wide. Epidemiological research has 
shown a dose-dependent association between alcohol con-
sumption and breast cancer. His overview highlighted the 
mechanisms by which alcohol consumption could increase 
the risk of developing breast cancer.
  If the observed relationship for alcohol is causal, re-
sults suggest that about 4% of the breast cancers in devel-
oped countries are attributable to alcohol. Clinicians need to 
inform women of the link between alcohol and breast cancer, 
since the use of alcohol is under-reported and rarely explored 
in depth––even in epidemiological research. The relation-
ship between alcohol and breast cancer should be stressed 
even for women who do not admit to alcohol use, given the 
poor rate of intake estimation in most clinical settings.
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